# Coupling the MAPK Slt2/ERK1 Pathway and IRE1-driven UPR Through Transcription Factor Rlm1/MEF2

**Authors:** Anish Chakraborty, Saswata Chakrabarty, Jagadeesh Kumar Uppala, Kimberly Ann Mayer, Anna J Evans, Jasmine George, Chandrima Ghosh, Ritisha Dey, An Phu Tran Nguyen, Nadege Gouignard, Pradeep Chaluvally-Raghavan, Madhusudan Dey

PMC · DOI: 10.21203/rs.3.rs-7292507/v1 · 2025-12-11

## TL;DR

This study reveals a new connection between the UPR and MAPK pathways through the Rlm1/MEF2 transcription factor in yeast.

## Contribution

The novel crosstalk between the MAPK pathway and IRE1-driven UPR via Rlm1/MEF2 is identified.

## Key findings

- The UPR has two phases: an early IRE1-dependent phase and a later phase involving Slt2/ERK1 and Rlm1/MEF2.
- Slt2 promotes IRE1 expression through Rlm1, revealing a new regulatory mechanism.
- Rlm1/MEF2 is a downstream target of Slt2/ERK1 and contributes to UPR regulation.

## Abstract

Unfolded protein response (UPR) is a conserved cellular strategy that enhances the protein folding capacity of cells under stress conditions. In Saccharomyces cerevisiae, the dual kinase RNase IRE1 initiates the UPR by catalyzing the cytosolic splicing of HAC1 mRNA, a process conserved in humans where IRE1 splices XBP1 mRNA. The spliced HAC1/XBP1 mRNA yields a transcription factor that upregulates the expression of protein-folding enzymes and chaperones, thereby boosting the cell’s ability to cope with unfolded proteins. Our study demonstrates that the UPR involves two distinct phases. The early phase operates predominantly through the canonical IRE1 signaling pathway, while the later phase involves additional regulation by the MAP kinase Slt2 or its human ortholog ERK1/ERK2/ERK5 and the downstream target the MADS-box transcription factor Rlm1 (an ortholog of human MEF2C). We further show that Slt2 promotes IRE1 expression through Rlm1. Together, these findings reveal a previously unrecognized crosstalk between the MAPK and IRE1-mediated arm of the UPR.

## Linked entities

- **Genes:** ERN1 (endoplasmic reticulum to nucleus signaling 1) [NCBI Gene 2081], HCN2 (hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2) [NCBI Gene 610], XBP1 (X-box binding protein 1) [NCBI Gene 7494], SLT2 (mitogen-activated serine/threonine-protein kinase SLT2) [NCBI Gene 856425], RLM1 (Disease resistance protein (TIR-NBS-LRR class) family) [NCBI Gene 842711], MEF2C (myocyte enhancer factor 2C) [NCBI Gene 4208]
- **Species:** Saccharomyces cerevisiae (taxon 4932)

## Full-text entities

- **Genes:** MAPK7 (mitogen-activated protein kinase 7) [NCBI Gene 5598] {aka BMK1, ERK4, ERK5, PRKM7}, MAPK1 (mitogen-activated protein kinase 1) [NCBI Gene 5594] {aka ERK, ERK-2, ERK2, ERT1, MAPK2, NS13}, MEF2C (myocyte enhancer factor 2C) [NCBI Gene 4208] {aka C5DELq14.3, DEL5q14.3, NEDHSIL}, HCN2 (hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2) [NCBI Gene 610] {aka BCNG-2, BCNG2, EIG17, FEB2, GEFSP11, HAC-1}, ERN1 (endoplasmic reticulum to nucleus signaling 1) [NCBI Gene 2081] {aka IRE1, IRE1P, IRE1a, hIRE1p}, MEF2A (myocyte enhancer factor 2A) [NCBI Gene 4205] {aka ADCAD1, RSRFC4, RSRFC9, mef2}, XBP1 (X-box binding protein 1) [NCBI Gene 7494] {aka TREB-5, TREB5, XBP-1, XBP2}, MAPK3 (mitogen-activated protein kinase 3) [NCBI Gene 5595] {aka ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1}
- **Species:** Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Homo sapiens (human, species) [taxon 9606]

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12776503/full.md

---
Source: https://tomesphere.com/paper/PMC12776503